2.228 Retrograde cold blood cardioplegia
Japanese Journal of Cardiovascular Surgery 1986;15(5):459-460
6.One Injection of DsRed Followed by Bites from Transgenic Mosquitoes Producing DsRed in the Saliva Elicits a High Titer of Antibody in Mice
Hiroyuki Matsuoka ; Gen-ichiro Sano ; Ryuta Hattori ; Hiroyuki Tomita ; Daisuke S. Yamamoto ; Makoto Hirai
Tropical Medicine and Health 2012;40(2):47-53
It has been proposed that transgenic mosquitoes can be used as a “flying syringe” for infectious disease control. We succeeded in generating a transgenic (TG) mosquito, Anopheles stephensi, excreting and discharging DsRed in saliva. DsRed was deposited on the membrane where the TG mosquito probed with its proboscis. Repeated feeding by the TG mosquitoes induced anti-DeRed as well as anti-SG antibodies in mice. This indicates that the TG mosquitoes can immunize the animal. Moreover, in this report, we employed a pre-immunization method before exposing mice to the TG mosquitoes. We injected DsRed to mice to prepare memory B cells and exposed the mice to bites by the TG mosquitoes excreting DsRed. The mice produced a higher titer of antibody to DsRed, suggesting that the bites from TG mosquitoes act as a booster and that primary immunization with a vaccine protein and exposure to TG mosquitoes excreting the vaccine protein in the saliva produces a synergistic effect.
7.Systemic and myelotoxic effects of single administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats.
Seigo YAMAMOTO ; Kasuke NAGANO ; Hideki SENOH ; Tetsuya TAKEUCHI ; Michiharu MATSUMOTO ; Hisao OHBAYASHI ; Tadashi NOGUCHI ; Kazunori YAMAZAKI ; Heihachiro ARITO ; Taijiro MATSUSHIMA
Environmental Health and Preventive Medicine 2006;11(3):136-144
OBJECTIVESystemic and myelotoxic effects of 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) were examined by the single administration of TBDD by gavage to rats.
METHODSFifteen Wistar rats of both sexes per group received 0, 10, 30, 100 or 300 μg TBDD/kg body weight. Rats surviving to the scheduled necropsy on Days 2, 7 and 36 after TBDD administration were examined for growth rate, organ weight, hematology, histopathology and adipose tissue levels of TBDD.
RESULTSThree 300 μg/kg-dosed females died on Days 21, 23 and 27, and exhibited a marked decrease in body weight, severe thymic atrophy, decreased bone marrow hematopoiesis and hemorrhage in the subarachnoid space of brain and spinal cord. TBDD-dosed surviving rats exhibited growth retardation, decreased bone marrow hematopoiesis, decreases in red blood cell counts, hemoglobin concentrations, and hematocrit values, an increase in reticulocytes and decreases in platelet counts, white blood cell counts and eosinophils. These signs suggested TBDD myelotoxicity. Splenic extramedullary hematopoiesis was increased in both sexes given TBDD, whereas atrophy of the splenic white pulp occurred only in TBDD-dosed females. Marked decreases in body weights and the size and weight of the thymus, severe thymic atrophy and death in TBDD-dosed females suggested a wasting syndrome. The adipose tissue level of TBDD culminated on Day 7 and decreased to 20-30% of the Day 7 level on Day 36.
CONCLUSIONSThe TBDD-induced effects were characterized by a wasting syndrome and myelotoxicity that appeared at the dose levels of 30 μg/kg and higher and caused death in 300 μg/kg-dosed females.
8.Expression of adhesion molecules on CD34+ cells from steady-state bone marrow before and after mobilization and their association with the yield of CD34+ cells.
Karin Zattar CECYN ; Eliza Y S KIMURA ; Dulce Marta S M LIMA ; Miyoko YAMAMOTO ; José Orlando BORDIN ; José Salvador R DE OLIVEIRA
Blood Research 2018;53(1):61-70
BACKGROUND: Cell adhesion molecules (CAMs) expressed on hematopoietic progenitor cells (HPCs), endothelial cells, and stromal cells play a pivotal role in the mobilization of CD34+ cells. Herein, we conducted a non-randomized peripheral blood stem cell (PBSC) mobilization study aimed to compare the potential differences in the expressions of several CAMs and chemokines on CD34+ cells obtained from bone marrow aspirate before and after HPC mobilization from patients with hematologic malignancies and healthy donors. METHODS: Three-color cytofluorometric analysis was used to compare the expressions of CAMs and chemokines in the bone marrow before and after mobilization. RESULTS: For all studied groups, CAM expression among those with good and poor yields of CD34+ cells was significantly correlated with VCAM-1 (P=0.007), CD44 (P=0.027), and VLA-4 (P=0.014) expressions. VCAM-1 (P=0.001), FLT-3 (P=0.001), CD44 (P=0.011), VLA-4 (P=0.001), and LFA-1 (P=0.001) expressions were higher before HPC mobilization than after HPC mobilization. By contrast, the expression of CXCR4 significantly varied before and after mobilization only among those with successful PBSC mobilization (P=0.002). CONCLUSION: We attempted to identify particular aspects of CAMs involved in CD34+ cell mobilization, which is a highly complex mechanism that involves adhesion molecules and matrix metalloproteases. The mechanism by which CD34+ cell mobilization is activated through proteolytic enzymes is not fully understood. We believe that CXCR4, VLA-4, CD44, and VCAM-1 are the most important molecules implicated in HPC mobilization, particularly because they show a correlation with the yield of CD34+ cells collected via large volume leukapheresis.
Bone Marrow*
;
Cell Adhesion Molecules
;
Chemokines
;
Endothelial Cells
;
Hematologic Neoplasms
;
Hematopoietic Stem Cells
;
Humans
;
Integrin alpha4beta1
;
Leukapheresis
;
Lymphocyte Function-Associated Antigen-1
;
Lymphoma, Non-Hodgkin
;
Metalloproteases
;
Multiple Myeloma
;
Peptide Hydrolases
;
Stem Cells
;
Stromal Cells
;
Tissue Donors
;
Vascular Cell Adhesion Molecule-1
9.ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head
Quanjun CUI ; Woo-Lam JO ; Kyung-Hoi KOO ; Edward Y. CHENG ; Wolf DRESCHER ; Stuart B. GOODMAN ; Yong-Chan HA ; Phillippe HERNIGOU ; Lynne C. JONES ; Shin-Yoon KIM ; Kyu Sang LEE ; Mel S. LEE ; Yun Jong LEE ; Michael A. MONT ; Nobuhiko SUGANO ; John TALIAFERRO ; Takuaki YAMAMOTO ; Dewei ZHAO
Journal of Korean Medical Science 2021;36(10):e65-
Osteonecrosis of the femoral head (ONFH) is a devastating disease frequently leading to femoral head collapse and hip arthritis. Specifically, non-traumatic ONFH primarily affects young and middle-aged adults. Although compromised local circulation of the femoral head seems to be pathognomonic for the disease, the pathogenesis is perplexing and continues to be an area of scrutiny and research. Comprehension of the pathogenesis is of crucial importance for developing and guiding treatments for the disease. Therefore, we provide an up-to-date consensus on the pathogenesis of non-traumatic ONFH.
10.ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head
Quanjun CUI ; Woo-Lam JO ; Kyung-Hoi KOO ; Edward Y. CHENG ; Wolf DRESCHER ; Stuart B. GOODMAN ; Yong-Chan HA ; Phillippe HERNIGOU ; Lynne C. JONES ; Shin-Yoon KIM ; Kyu Sang LEE ; Mel S. LEE ; Yun Jong LEE ; Michael A. MONT ; Nobuhiko SUGANO ; John TALIAFERRO ; Takuaki YAMAMOTO ; Dewei ZHAO
Journal of Korean Medical Science 2021;36(10):e65-
Osteonecrosis of the femoral head (ONFH) is a devastating disease frequently leading to femoral head collapse and hip arthritis. Specifically, non-traumatic ONFH primarily affects young and middle-aged adults. Although compromised local circulation of the femoral head seems to be pathognomonic for the disease, the pathogenesis is perplexing and continues to be an area of scrutiny and research. Comprehension of the pathogenesis is of crucial importance for developing and guiding treatments for the disease. Therefore, we provide an up-to-date consensus on the pathogenesis of non-traumatic ONFH.